Helicobacter pylori infection in patients undergoing gastric bypass surgery for morbid obesity

被引:46
|
作者
Renshaw, AA [1 ]
Rabaza, JR
Gonzalez, AM
Verdeja, JC
机构
[1] Baptist Hosp Miami, Dept Pathol, Miami, FL 33176 USA
[2] Baptist Hosp Miami, Dept Surg, Miami, FL 33176 USA
关键词
Helicobacter pylori; morbid obesity; gastric bypass; gastritis;
D O I
10.1381/096089201321336601
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Studies suggest that the incidence of Helicobacter pylori infection in obese patients, including those undergoing gastric reduction surgery, may be increased. Methods: We examined the histologic findings at the time of surgery in a series of patients who were undergoing Roux-en-Y gastric bypass (RYGBP) for morbid obesity and compared these results with patients in our institution undergoing endoscopy. Results: Of 60 patients undergoing RYGBP, material for histologic examination was available in 56 cases, and in 40 cases gastric fundic mucosa from the anastomotic site was sampled at the time of surgery. Active chronic gastritis was present in 6 (15%), and chronic gastritis was present in 27 (68%). H. pylori was present in all 6 cases of active chronic gastritis and in 9 cases of chronic gastritis (total 38%). This incidence of H.pylori infection was higher than that found in the series of gastric biopsies (107/500, 21%, p = 0.03) and fundic biopsies (10/80, 13%, p = 0.003), but was not different when compared with age-matched gastric biopsies (44/177, 25%, p = 0.12). Conclusions: The incidence of H,pylori in patients undergoing RYGBP was higher than that found in all patients undergoing endoscopy and biopsy and than those undergoing fundic biopsies, but not higher when age-matched controls were considered.
引用
收藏
页码:281 / 283
页数:3
相关论文
共 50 条
  • [41] Helicobacter pylori infection in patients with gastric adenocarcinoma
    Wu, CW
    Wu, TC
    Chang, YR
    Tsay, SH
    Yin, SJ
    Lui, WY
    Peng, FK
    Chi, CW
    [J]. TUMORI, 1996, 82 (01) : 40 - 44
  • [42] Stenosis in gastric bypass for morbid obesity
    de-la-Cruz-Vigo, F.
    de-la-Cruz-Vigo, J. L.
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2010, 102 (03) : 151 - 154
  • [43] GASTRIC BYPASS FOR MORBID-OBESITY
    GRIFFEN, WO
    [J]. SURGICAL CLINICS OF NORTH AMERICA, 1979, 59 (06) : 1103 - 1112
  • [44] GASTRIC BYPASS IN MORBID-OBESITY
    MASON, EE
    PRINTEN, KJ
    BLOMMERS, TJ
    LEWIS, JW
    SCOTT, DH
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1980, 33 (02): : 395 - 405
  • [45] Gastric bypass with an anastomosis for morbid obesity
    Richardsen, Andrea J.
    Chahal-Kummen, Monica
    Kristinsson, Jon A.
    Sovik, Torgeir Thorson
    Eribe, Inger Elisabeth Lokken
    Mala, Tom
    [J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2023, 143 (16) : 1400 - 1405
  • [46] Helicobacter pylori Eradication Therapy in Obese Patients Undergoing Gastric Bypass Surgery-Fourteen Days Superior to Seven Days?
    Cerqueira, Rute Maria
    Conceicao Manso, M.
    Correia, Manuel R.
    Fernandes, Carolina D.
    Vilar, Helder
    Nora, Mario
    Martins, Paulo
    [J]. OBESITY SURGERY, 2011, 21 (09) : 1377 - 1381
  • [47] LATE RESULTS OF GASTRIC BYPASS-SURGERY FOR MORBID-OBESITY
    REINHOLD, RB
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 1994, 13 (04) : 326 - 331
  • [48] Altered Hypoglycemia Counterregulation following Gastric Bypass Surgery for Morbid Obesity
    Abrahamsson, Niclas
    Borjesson, Joey Lau
    Sundbom, Magnus
    Karlsson, Anders F.
    Eriksson, Jan W.
    [J]. DIABETES, 2016, 65 : A506 - A506
  • [49] Gastric bypass surgery is associated with a high risk of hypoglycaemia in morbid obesity
    Brix, J. M.
    Kopp, H. P.
    Schermann, M.
    Schernthaner, G. H.
    Schernthaner, G.
    [J]. DIABETOLOGIA, 2012, 55 : S257 - S257
  • [50] Modified antireflux monoanastomotic laparoscopic gastric bypass in morbid obesity surgery
    Klymenko, A., V
    Klymenko, V. M.
    Bilai, A., I
    Nikolaiev, M., V
    [J]. ZAPOROZHYE MEDICAL JOURNAL, 2020, 22 (05) : 676 - 681